Literature DB >> 29863812

Scottish Bowel Screening Programme colonoscopy quality - scope for improvement?

A J Quyn1, C G Fraser1, G Stanners2, F A Carey3, C J Rees4,5, B Moores6, R J Steele1.   

Abstract

AIM: The delivery of the Scottish Bowel Screening Programme (SBoSP) is rooted in the provision of a high quality, effective and participant-centred service. Safe and effective colonoscopy forms an integral part of the process. Additional accreditation as part of a multi-faceted programme for participating colonoscopists, as in England, does not exist in Scotland. This study aimed to describe the quality of colonoscopy in the SBoSP and compare this to the English national screening standards.
METHODS: Data were collected from the SBoSP between 2007 and 2014. End-points for analysis were caecal intubation, cancer, polyp and adenoma detection, and complications. Overall results were compared with 2012 published English national standards for screening and outcomes from 2006 to 2009.
RESULTS: During the study period 53 332 participants attended for colonoscopy. The colonoscopy completion rate was 95.6% overall. The mean cancer detection rate was 7.1%, the polyp detection rate was 45.7% and the adenoma detection rate was 35.5%. The overall complication rate was 0.47%.
CONCLUSION: Colonoscopy quality in the SBoSP has exceeded the standard set for screening colonoscopy in England, despite not adopting a multi-faceted programme for screening colonoscopy. However, the overall adenoma detection rate in Scotland was 9.1% lower than that in England which has implications for colonoscopy quality and may have an impact on cancer prevention rates, a key aim of the SBoSP. Colorectal Disease
© 2018 The Association of Coloproctology of Great Britain and Ireland.

Entities:  

Keywords:  Screening colonoscopy; performance

Mesh:

Year:  2018        PMID: 29863812     DOI: 10.1111/codi.14281

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  2 in total

1.  Calibrating Natural History of Cancer Models in the Presence of Data Incompatibility: Problems and Solutions.

Authors:  Olena Mandrik; Chloe Thomas; Sophie Whyte; James Chilcott
Journal:  Pharmacoeconomics       Date:  2022-01-07       Impact factor: 4.558

2.  Adverse events of colonoscopy in a colorectal cancer screening program with fecal immunochemical testing: a population-based observational study.

Authors:  Bernard Denis; Isabelle Gendre; Sarah Weber; Philippe Perrin
Journal:  Endosc Int Open       Date:  2021-02-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.